19.03.2018 - 21.03.2018Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, USA
Time: 9:00 am to 4:00 pm.
Conference themes Returning for the 4th time, ICI Boston is the definitive forum focused exclusively on how to deliver maximum clinical benefit through immune checkpoint modulation.
Rather than attempting to cover the entire IO space and only providing superficial insights, this conference has the focus required to drill down into the real details. Discover how to overcome key preclinical, translational and clinical drug development challenges encountered in the development of checkpoint modulators.
Professional congress organizer (PCO) Hanson Wade
Notes Roger Dansey (Merck), Israel Lowy (Regeneron), Corinne Reimer (AstraZeneca), Bernard Fox (Providence Cancer Center), Bill Grossman (Genentech), Amy Peterson (BeiGene), Lata Jayaraman (Seres Therapeutics) and many more.
